Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines

By Rogers P.   Boxall F.E.   Allott C.P.   Stephens T.C.   Kelland L.R.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1653-1660

Elsevier

Access to resources Recommend Favorite

Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells

By Ong Pei-Shi   Wang Xin-Qiao   Lin Hai-Shu   Chan Sui-Yung   Ho Paul C.  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1705-1713

Spandidos Publications

Access to resources Recommend Favorite

Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells

By Marverti Gaetano   Ligabue Alessio   Lombardi Paolo   Ferrari Stefania   Monti Maria Giuseppina   Frassineti Chiara   Costi Maria Paola  

International Journal of Oncology, Vol. 43, Iss. 4, 2013-10 ,pp. : 1269-1280

Spandidos Publications

Access to resources Recommend Favorite

Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle

By                            

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 923-933

Spandidos Publications

Access to resources Recommend Favorite

Apoptosis as a Measure of Chemosensitivity to Cisplatin and Taxol Therapy in Ovarian Cancer Cell Lines

By Gibb R.K.   Taylor D.D.   Wan T.   O'Connor D.M.   Doering D.L.   Gercel-Taylor C.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 13-22

Elsevier

Access to resources Recommend Favorite